Antisense Pharma News
Most Popular Antisense Pharma Story
Rhythm Pharma raises $21M for metabolic diseases
Rhythm Pharmaceuticals has completed a Series A equity financing of $21 million in a round led by MPM Capital and New Enterprise Associates. The funds will be used to develop products licensed from Read more...
Latest Headlines
- March 15, 2010
- November 9, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
